New drug safety check for Hard-to-Treat blood cancer
NCT ID NCT03934684
First seen May 11, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study looked at the safety of the drug Kyprolis (carfilzomib) in 101 Indian adults whose multiple myeloma had come back or stopped responding to treatment. Researchers tracked side effects and how long patients lived without their cancer getting worse. The goal was to confirm the drug's safety under its approved label, not to find a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Apollo Hospital
Hyderabad, Andhra Pradesh, 500033, India
-
Aster Medcity
Kochi, Kerala, 682027, India
-
Cancer Institute WIA
Chennai, Tamil Nadu, 600020, India
-
Cytecare Cancer Hospitals
Bengaluru, Karnataka, 560064, India
-
Deenanath Mangeshkar Hospital and Research Centre
Pune, Maharashtra, 411004, India
-
Government Medical College
Kozhikode, Kerala, 673008, India
-
Heath Care Group Manavata Cancer Centre
Nashik, Maharashtra, 422 004, India
-
Jawaharlal Institute of Postgraduate Medical Education and Research
Puducherry, Puducherry, 605 006, India
-
K L E S Dr Prabhakar Kore Hospital and Medical Research Centre
Belagavi, Karnataka, 590010, India
-
M S Ramaiah Memorial Hospital
Bangalore, Karnataka, 560054, India
-
Mumbai Oncocare Center
Mumbai, Maharashtra, 400 056, India
-
Navsanjeevani Hospital
Nashik, Maharashtra, 422 002, India
-
Netaji Subhash Chandra Bose Cancer Research Institute
Kolkata, West Bengal, 700 094, India
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400 012, India
-
Thangam Cancer Centre
Namakkal, Tamil Nadu, 637001, India
-
Valentis Cancer Hospital
Meerut, Uttar Pradesh, 250001, India
-
Yashoda Hospital
Hyderabad, Andhra Pradesh, 500 082, India
Conditions
Explore the condition pages connected to this study.